These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 810615)

  • 1. [Comparison between SM daily and twice weekly treatment in the regimen of SM, INH and PAS--particularly considering the degree of drug resistance-- (report 1) (author's transl)].
    Baba H; Azuma Y
    Kekkaku; 1975 Jul; 50(7):191-7. PubMed ID: 810615
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison between SM daily and twice weekly treatment in the regimen of SM, INH and PAS--particularly considering the degree of drug resistance (Report 2) (author's transl)].
    Baba H; Azuma Y
    Kekkaku; 1977 Dec; 52(12):619-26. PubMed ID: 604603
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
    Kekkaku; 1972 Jun; 47(6):151-8. PubMed ID: 5081204
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of initial combined chemotherapy with SM, INH and EB for pulmonary tuberculosis. 2. Comparison of SM, EB and INH regimen with that of SM, PAS and INH for experimental tuberculosis of mice].
    Makiyama H
    Kekkaku; 1971 Aug; 46(8):303-8. PubMed ID: 5570128
    [No Abstract]   [Full Text] [Related]  

  • 5. [[Comparative studies on therapeutic effects of SM.INH.PAS, SM.INH.PAS.EB twice weekly, and SM.INH.PAS.EB daily in original treatment cases of pulmonary tuberculosis].
    Kekkaku; 1971 Aug; 46(8):325-33. PubMed ID: 4998863
    [No Abstract]   [Full Text] [Related]  

  • 6. [A controlled comparison of daily and intermittent triple drug regimens (SM-INH-EB) in original treatment. Report of the 16th series of Controlled Trial of Chemotherapy (author's transl)].
    Kekkaku; 1974 Aug; 49(8):247-52. PubMed ID: 4427402
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of high dose INH twice weekly regimen in the original treatment for moderately advanced pulmonary tuberculosis. A report of the 12th series B study of the controlled trials].
    Kekkaku; 1972 Jun; 47(6):159-66. PubMed ID: 4562924
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
    Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ambulatory intermittent chemotherapy of patients with newly detected pulmonary tuberculosis].
    Rudoĭ NM; Simonian LK
    Klin Med (Mosk); 1973 Jul; 51(7):89-92. PubMed ID: 4786268
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug resistance among previously treated tuberculosis patients, a brief report.
    Costello HD; Caras GJ; Snider DE
    Am Rev Respir Dis; 1980 Feb; 121(2):313-6. PubMed ID: 6767427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical significance of the critical drug resistance concentration of SM,INH and PAS].
    Baba H; Azuma Y
    Kekkaku; 1972 Oct; 47(10):353-60. PubMed ID: 4658707
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical value of the complex determination of the drug resistance of Mycobacterium tuberculosis].
    Gur'ian IE
    Sov Med; 1973 Apr; 36(4):94-7. PubMed ID: 4203677
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative data on the study of single and fractional use of antitubercular agents of the first order in the treatment of tuberculosis in children and adolescents].
    Firsova VA; Kupish SG; Ivanova AI; Maslauskene TP; Novruzov MA
    Vopr Okhr Materin Det; 1976; 21(3):52-4. PubMed ID: 1086033
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid].
    Favez G; Gonin JD; Gubéran E; de Kalbermatten JP; Vulliémoz P; Willa C
    Schweiz Med Wochenschr; 1969 Feb; 99(5):150-6. PubMed ID: 4974643
    [No Abstract]   [Full Text] [Related]  

  • 15. A triple regimen of streptomycin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 2.
    Oka S; Kayaba K
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):106-9. PubMed ID: 5525311
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of early detected destructive pulmonary tuberculosis].
    Anfilof'eva OIu; fedotova ZN
    Probl Tuberk; 1974; (12):38-41. PubMed ID: 4445134
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preliminary findings and considerations on primary resistance to SM, INI, and PAS in the Provincial Antitubercular Association of Naples].
    Romano S; Grella G
    Rass Int Clin Ter; 1966 Dec; 46(23):1311-6. PubMed ID: 5997869
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of initial combined chemotherapy with SM, INH and EB for pulmonary tuberculosis. I. Clinical comparison of SM, INH and EB regimen with SM, INH and PAS regimen].
    Makiyama H
    Kekkaku; 1969 Jun; 44(6):181-7. PubMed ID: 5805784
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of 1.0g streptomycin, 0.5g streptomycin and 1.0g capreomycin three times a week combined with PAS and isoniazid in original treatment for pulmonary tuberculosis. Report of the 17th series of controlled trial of chemotherapy (author's transl)].
    Kekkaku; 1976 Jul; 51(7):271-8. PubMed ID: 61302
    [No Abstract]   [Full Text] [Related]  

  • 20. Controlled comparison of oral twice-weekly and oral daily isoniazid plus PAS in newly diagnosed pulmonary tuberculosis.
    Br Med J; 1973 Apr; 2(5857):7-11. PubMed ID: 4633061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.